Hemogenyx Pharmaceuticals Plc
HEMO.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£5,619 | -£6,691 | -£3,987 | -£5,108 |
| Dep. & Amort. | £639 | £646 | £195 | £126 |
| Deferred Tax | £0 | £0 | £0 | -£18 |
| Stock-Based Comp. | £0 | £0 | £18 | £153 |
| Change in WC | £603 | -£834 | £243 | £101 |
| Other Non-Cash | £260 | £773 | £621 | £2,118 |
| Operating Cash Flow | -£4,117 | -£6,106 | -£2,911 | -£2,627 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£13 | -£117 | -£429 | -£818 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | -£2 | -£139 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£12 | £85 | £11 | £18 |
| Investing Cash Flow | -£25 | -£32 | -£420 | -£939 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£635 | -£639 | -£110 | -£3,222 |
| Stock Issued | £3,712 | £5,088 | £0 | £12,000 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | £3,077 | £4,449 | -£110 | £8,778 |
| Forex Effect | -£24 | £403 | -£876 | -£183 |
| Net Chg. in Cash | -£1,088 | -£1,285 | -£4,308 | £5,029 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1,248 | £2,533 | £6,841 | £1,812 |
| End Cash | £159 | £1,248 | £2,533 | £6,841 |
| Free Cash Flow | -£4,130 | -£6,223 | -£3,340 | -£3,445 |